At Lone Star Center for Health and Wellness, we understand that each individual has unique health needs
- when there is risk of torsades de pointes, for example in patients with prolonged QT, concomitant administration of other medications that produce torsades de pointes (amiodarone, quinidine, bepridil, IV erythromycin, halofrantine, pentamidine, sparfloxacin, sultopride, vincamine, betrilio, disopyramide, sotalol, etc)
It is intended exclusively for scientific research conducted by qualified personnel in certified facilities.
Clinical trials show retatrutide can reduce body weight by up to 24% after 48 weeks, significantly outperforming many current obesity treatments
They produce NPY and AgRP, which are the initial targets of leptin action
PMC 5788147